Adamis Pharma Stock Market Capitalization
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Adamis Pharma fundamentals help investors to digest information that contributes to Adamis Pharma's financial success or failures. It also enables traders to predict the movement of Adamis Stock. The fundamental analysis module provides a way to measure Adamis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adamis Pharma stock.
Adamis |
Adamis Pharma Company Market Capitalization Analysis
Adamis Pharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Adamis Pharma Market Capitalization | 7.25 M |
Most of Adamis Pharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adamis Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Adamis Pharma is about 7.25 M. This is 99.94% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The market capitalization for all United States stocks is 99.96% higher than that of the company.
Adamis Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adamis Pharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adamis Pharma could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics of similar companies.Adamis Pharma is currently under evaluation in market capitalization category among its peers.
Adamis Fundamentals
| Return On Equity | -7.85 | |||
| Return On Asset | -1.04 | |||
| Operating Margin | (3.74) % | |||
| Current Valuation | 7.28 M | |||
| Shares Outstanding | 9.36 M | |||
| Shares Owned By Insiders | 7.81 % | |||
| Shares Owned By Institutions | 16.59 % | |||
| Number Of Shares Shorted | 98.94 K | |||
| Price To Earning | (6.21) X | |||
| Price To Book | 8.62 X | |||
| Price To Sales | 17.64 X | |||
| Revenue | 4.76 M | |||
| Gross Profit | (1.43 M) | |||
| EBITDA | (24.27 M) | |||
| Net Income | (26.48 M) | |||
| Cash And Equivalents | 8.88 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 342.56 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | (4.24) X | |||
| Cash Flow From Operations | (25.9 M) | |||
| Short Ratio | 0.02 X | |||
| Earnings Per Share | (10.14) X | |||
| Target Price | 0.42 | |||
| Number Of Employees | 11 | |||
| Beta | 1.28 | |||
| Market Capitalization | 7.25 M | |||
| Total Asset | 10.93 M | |||
| Retained Earnings | (304.56 M) | |||
| Working Capital | (2.12 M) | |||
| Current Asset | 4.15 M | |||
| Current Liabilities | 2.75 M | |||
| Z Score | -33.43 | |||
| Net Asset | 10.93 M |
About Adamis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adamis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adamis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adamis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Adamis Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adamis Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adamis Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Adamis Stock
Moving against Adamis Stock
| 0.89 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.87 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.84 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.79 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.75 | HPQ | HP Inc | PairCorr |
The ability to find closely correlated positions to Adamis Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adamis Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adamis Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adamis Pharma to buy it.
The correlation of Adamis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adamis Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adamis Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adamis Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |